Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Titel:
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Auteur:
Wong, Vanessa de Boer, Richard Baron-Hay, Sally Blum, Robert Boyle, Frances Chua, Susan Clarke, Kerrie Cuff, Katharine Green, Michael Lim, Elgene Mok, Kelly Nott, Louise Nottage, Michelle Tafreshi, Ali Tsoi, Daphne Uccellini, Anthony Hong, Wei Gibbs, Peter Lok, Sheau Wen